Camden National director receives 317-share stock award

Haynes Larry K reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Haynes Larry K reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Larry K. Haynes reported receiving 317 shares of Common Stock as a stock award. The shares were granted at $45.26 per share as compensation under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees.

Following this grant, Haynes directly owns 3,184.831 Camden National shares. A portion of this position, 23.893 shares, has been accumulated since the prior filing through participation in the company's dividend reinvestment program.

Insider Trade Summary

Grant/Award: 317 shares

Grant/Award 1 txn

Insider Haynes Larry K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	317	$45.26	$14K

Holdings After Transaction: Common Stock — 3,184.831 shares (Direct)

Footnotes (2)

1. F1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.
2. F2. Consists of 23.893 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Larry K. Haynes report for CAMDEN NATIONAL CORP (CAC)?

Director Larry K. Haynes reported acquiring 317 shares of Camden National Common Stock. The shares were granted as a stock award under the 2022 Equity and Incentive Plan, received in lieu of cash director fees, and increased his directly held position disclosed in this filing.

How many Camden National (CAC) shares does Larry K. Haynes hold after this Form 4?

After the reported grant, Larry K. Haynes directly holds 3,184.831 Camden National shares. This total includes the newly awarded 317 shares and 23.893 shares accumulated since the prior filing through participation in the company’s dividend reinvestment program.

Was the CAC insider transaction by Larry K. Haynes a market purchase or a stock award?

The CAC insider transaction was a stock award, not a market purchase. Larry K. Haynes received 317 shares of Common Stock as a grant under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees, according to the Form 4 details.

At what price were the 317 CAC shares granted to Larry K. Haynes?

The 317 shares of Camden National Common Stock were granted to Larry K. Haynes at $45.26 per share. This price is reported in the Form 4 transaction details describing the non-derivative acquisition classified as a grant or award under the company’s equity and incentive plan.

What role does Camden National’s dividend reinvestment program play in Larry K. Haynes’s holdings?

Larry K. Haynes’s holdings include 23.893 shares acquired through Camden National’s dividend reinvestment program. These shares were accumulated since the last filing as dividends were automatically reinvested into additional Common Stock, modestly increasing his direct ownership over time.

Is the Larry K. Haynes CAC Form 4 transaction a buy or sell signal for investors?

The Form 4 shows an equity award, not an open-market buy or sell. Haynes received 317 shares as compensation under the 2022 Equity and Incentive Plan, a routine director fee arrangement rather than a discretionary trading decision in Camden National stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Haynes Larry K

(Last) (First) (Middle)

2 ELM STREET

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		A		317(1)	A	$45.26	3,184.831(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

2. Consists of 23.893 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

Remarks:

	Christopher G. Hutchinson, POA	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)